20 Feb 2008: NorDiag ASA invites to a breakfast presentation of the fourth quarter 2007 on February 27 2008 at 8:30am, at Thon Hotel Vika Atrium, Munkedamsveien 45, Oslo.

Please confirm your participation to elin.flo@nordiag.com or by calling 55 54 39 60. Shareholders who wish to receive the quarterly report by mail are requested to send an email regarding this to the same email address.

The fourth quarter report and the presentation will be published on NorDiag`s homepage www.nordiag.com.

Contact:
CEO Mårten Wigstøl
Phone. +47 911 65775

About NorDiag ASA:
NorDiag is a biotechnology company developing, manufacturing and marketing of automated solutions, instruments and tests, for diagnostic of cancer and infectious diseases. The Company`s first product in cancer diagnosis is Genefec TM for diagnosis of colorectal cancer. NorDiag has also launched a product for diagnostic of sexual transmitted infectious. In addition, the company has other applications for early diagnosis of cancer under development, as well as applications for other infectious diseases in the product pipeline. NorDiag is listed on Oslo Stock Exchange with the ticker NORD.